Neurogene Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
Neurogene Inc. (NGNE) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $81.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-07.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2019-03-07
- Neurogene Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- Neurogene Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2016-09-30 was $8.00K.
- Neurogene Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2016-06-30 was $23.00K, a 76.92% increase year-over-year.
- Neurogene Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2016-03-31 was $50.00K.
- Neurogene Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2016 was $81.00K.
- Neurogene Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2015 was -$52.00K, a 105.48% decline from fiscal 2014.
- Neurogene Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2014 was $949.00K, a 1.35% decline from fiscal 2013.
- Neurogene Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2013 was $962.00K.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 123 month |
|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $8.00K derived: sum of 2 quarters · filed 2019-03-07 | $31.00K derived: sum of 3 quarters · filed 2019-03-07 | $81.00K 10-K · filed 2019-03-07 | |||||
| 2016-09-30 | $8.00K 10-Q · filed 2017-11-08 | $31.00K derived: sum of 2 quarters · filed 2017-11-08 | $81.00K 10-Q · filed 2017-11-08 | $99.00K derived: sum of 4 quarters · filed 2018-03-12 | |||||
| 2016-06-30 | $23.00K 10-Q · filed 2017-08-08 | $73.00K 10-Q · filed 2017-08-08 | $91.00K derived: sum of 3 quarters · filed 2018-03-12 | $15.00K derived: sum of 4 quarters · filed 2018-03-12 | |||||
| 2016-03-31 | $50.00K 10-Q · filed 2017-05-09 | $68.00K derived: sum of 2 quarters · filed 2018-03-12 | -$8.00K derived: sum of 3 quarters · filed 2018-03-12 | $5.00K derived: sum of 4 quarters · filed 2018-03-12 | |||||
| 2015-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$58.00K derived: sum of 2 quarters · filed 2018-03-12 | -$45.00K derived: sum of 3 quarters · filed 2018-03-12 | -$52.00K 10-K · filed 2018-03-12 | |||||
| 2015-09-30 | -$76.00K 10-Q · filed 2016-11-09 | -$63.00K derived: sum of 2 quarters · filed 2016-11-09 | -$70.00K 10-Q · filed 2016-11-09 | -$79.00K derived: sum of 4 quarters · filed 2017-03-09 | |||||
| 2015-06-30 | $13.00K 10-Q · filed 2016-08-04 | $6.00K 10-Q · filed 2016-08-04 | -$3.00K derived: sum of 3 quarters · filed 2017-03-09 | $26.00K derived: sum of 4 quarters · filed 2017-03-09 | |||||
| 2015-03-31 | -$7.00K 10-Q · filed 2016-05-10 | -$16.00K derived: sum of 2 quarters · filed 2017-03-09 | $13.00K derived: sum of 3 quarters · filed 2017-03-09 | $27.50K derived: sum of 4 quarters · filed 2017-03-09 | |||||
| 2014-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $20.00K derived: sum of 2 quarters · filed 2017-03-09 | $34.50K derived: sum of 3 quarters · filed 2017-03-09 | $949.00K 10-K · filed 2017-03-09 | $949.18K 10-K · filed 2015-03-16 | ||||
| 2014-09-30 | $29.00K 10-Q · filed 2015-11-10 | $29.39K 10-Q · filed 2014-11-04 | $43.50K derived: sum of 2 quarters · filed 2015-11-10 | $958.00K 10-Q · filed 2015-11-10 | $957.82K 10-Q · filed 2014-11-04 | $946.74K derived: sum of 4 quarters · filed 2016-03-14 | |||
| 2014-06-30 | $14.00K 10-Q · filed 2015-08-06 | $928.00K 10-Q · filed 2015-08-06 | $928.43K 10-Q · filed 2014-08-11 | $917.74K derived: sum of 3 quarters · filed 2016-03-14 | $942.62K derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | $914.00K 10-Q · filed 2015-05-12 | $913.93K 10-Q · filed 2014-05-13 | $903.24K derived: sum of 2 quarters · filed 2016-03-14 | $928.11K derived: sum of 3 quarters · filed 2016-03-14 | $1.88M derived: sum of 4 quarters · filed 2016-03-14 | $2.10M 10-Q · filed 2014-05-13 | |||
| 2013-12-31 | -$10.76K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $14.11K derived: sum of 2 quarters · filed 2016-03-14 | $962.00K derived: sum of 3 quarters · filed 2016-03-14 | $962.00K 10-K · filed 2016-03-14 | $961.64K 10-K · filed 2015-03-16 | ||||
| 2013-09-30 | $24.87K 10-Q · filed 2014-11-04 | $972.76K derived: sum of 2 quarters · filed 2014-11-04 | $972.76K 10-Q · filed 2014-11-04 | ||||||
| 2013-06-30 | $947.89K 10-Q · filed 2014-08-11 | $947.89K 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |